首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Peroxisome proliferator‐activated receptor γ gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients
【2h】

Peroxisome proliferator‐activated receptor γ gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients

机译:过氧化物酶体增殖物激活受体γ基因多态性与日本2型糖尿病患者的血清甘油三酯水平和体重指数相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peroxisome proliferator‐activated receptor γ (PPARγ) controls adipocyte differentiation and regulates lipid and glucose homeostasis. Therefore, the PPARγ gene may affect insulin sensitivity and resistance. We analyzed the relationship between C/T exon 6 polymorphism of the PPARγ gene and various clinical parameters in type 2 diabetic patients. There were no significant differences in the frequencies of genotype and allele between diabetic patients with and without nephropathy. Diabetic patients were divided into two groups: patients bearing at least one T allele (CT/TT), and patients with no T allele (CC). Levels of serum triglyceride and body mass index (BMI) were significantly higher in the CT/TT genotype group than in the CC genotype group. Since obesity affects insulin resistance, the diabetic patients were also divided into two groups: those with a BMI of <23, and those with a BMI of >23. In patients with a BMI of <23, there was no significant change in the levels of glycosylated hemoglobin A1c (HbA1c) between the CC and CT/TT genotype groups. However, in patients with a BMI of >23, HbA1c levels were significantly higher in the CT/TT genotype group than in the CC genotype group. It appears that the CT/TT genotype with PPARγ gene polymorphism may contribute to higher BMI and higher serum triglyceride and HbA1c levels in Japanese type 2 diabetic patients. J. Clin. Lab. Anal. 18:317–321, 2004. © 2004 Wiley‐Liss, Inc.
机译:过氧化物酶体增殖物激活受体γ(PPARγ)控制脂肪细胞分化并调节脂质和葡萄糖稳态。因此,PPARγ基因可能会影响胰岛素的敏感性和抵抗力。我们分析了PPARγ基因的C / T外显子6多态性与2型糖尿病患者各种临床指标之间的关系。有和没有肾病的糖尿病患者之间的基因型和等位基因频率没有显着差异。糖尿病患者分为两组:携带至少一个T等位基因(CT / TT)的患者和没有T等位基因(CC)的患者。 CT / TT基因型组的血清甘油三酸酯和体重指数(BMI)水平显着高于CC基因型组。由于肥胖会影响胰岛素抵抗,因此糖尿病患者也分为两组:BMI <23和BMI> 23。在BMI <23的患者中,CC和CT / TT基因型组之间的糖基化血红蛋白A1c(HbA1c)水平没有显着变化。但是,在BMI> 23的患者中,CT / TT基因型组的HbA1c水平显着高于CC基因型组。在日本2型糖尿病患者中,具有PPARγ基因多态性的CT / TT基因型似乎可能导致更高的BMI和更高的血清甘油三酸酯和HbA1c水平。 J.临床实验室肛门18:317–321,2004年。©2004 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号